Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
about
Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.Striatal Circuits as a Common Node for Autism PathophysiologyAutism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?Altered Neuronal and Circuit Excitability in Fragile X Syndrome.The contribution of inhibitory interneurons to circuit dysfunction in Fragile X SyndromeNeuroligins provide molecular links between syndromic and nonsyndromic autismTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesSelective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid.Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play.Endocannabinoid signalling modulates susceptibility to traumatic stress exposureEndogenous cannabinoid signaling at inhibitory interneurons.Fragile X targeted pharmacotherapy: lessons learned and future directions.Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and AutismCell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling.Presynaptic long-term depression mediated by Gi/o-coupled receptors.Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndromeMedical marijuana: review of the science and implications for developmental-behavioral pediatric practice.Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome.Functional and structural deficits at accumbens synapses in a mouse model of Fragile X.Organic carbamates in drug design and medicinal chemistryPostnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol lipase does not cause neurodegeneration in neonatal mice.Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome.Endocannabinoid Signaling in AutismEndocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal CortexFasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathwaysElevated CaMKIIα and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model.Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signalingMetabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis.Fmr1 deletion enhances and ultimately desensitizes CB(1) signaling in autaptic hippocampal neurons.Elucidating cannabinoid biology in zebrafish (Danio rerio).A Primary Cortical Input to Hippocampus Expresses a Pathway-Specific and Endocannabinoid-Dependent Form of Long-Term Potentiation.Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.FMRP regulates actin filament organization via the armadillo protein p0071.More surprises lying ahead. The endocannabinoids keep us guessing.Late onset deficits in synaptic plasticity in the valproic acid rat model of autismThe role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a.
P2860
Q26748761-14AC198A-A56C-4EC8-AA26-6FA9C459E772Q26768226-B58CA627-1930-45A6-8248-C46222FDAD54Q26768231-217F9615-6D5C-49F2-825B-0B638087D80BQ26796317-0D792763-11FE-4D22-BCCE-E7AF4C12425BQ26998540-45358D07-054F-4C3F-B938-93C0363E6D88Q27015370-EB60C619-F17A-471A-97A1-FAF4F0FDD315Q27023257-53E39AC7-5F04-42B1-8D1F-6F2BDD03189AQ30376422-318D30C1-BC90-426D-8F37-491518BB2340Q30818488-87D1A593-26D1-4EA6-8408-E9303A139BC7Q30828780-C2FCC1D4-BABF-444C-AADF-EFD1872FFFB3Q30843851-9DA613A6-99A7-4667-BCDC-1545BB0C83C4Q33624983-8DD22D4E-8D06-40B5-83B9-FB8B43B6F203Q33785983-03BE4745-953D-4C6A-93E6-C9A515ECED4EQ33877423-04ED31CD-FFAC-4E37-96A6-7CEC8CB8832FQ34452582-DB157032-F722-4447-A685-BDDE4B6A0E77Q34614351-80F09BDF-0755-4BB5-AC0B-01F81DD50FAFQ35035766-960B888C-4AC3-4112-A67F-65239FBB7088Q35053208-86CFAB15-CA15-4A37-85F6-079F47617173Q35142914-52764F9E-7245-4145-8D7A-4177C2A1266AQ35218838-21D0913E-95F3-4CEB-84A6-851BCB140149Q35365543-755CAF1A-8C10-412B-896F-8446FE80DDC4Q35815626-AC905F1C-EEA0-48BD-AC66-FCD0924D6DA2Q36008447-B8CE29BB-9468-4FD8-8236-BDB0CA83C7F1Q36157617-C904EE3A-EB50-4923-9D76-A7BDEFF9F8EDQ36332761-807AEB2D-5FAC-4FB6-8D19-0575C3113333Q36339330-D0BAF1B7-069A-4776-AE39-6840F89B4CC5Q36387172-FD65D0DE-46C6-4D4F-8D4B-34A504D7F3EBQ36612284-E3CA549A-DDEC-4A7D-BDB3-A3F1CB6D3887Q36717066-F93F41B8-8916-4CF3-BEA7-EB9CB5A698F0Q36850573-AC12041B-3074-4E45-B33E-03F0D555E54CQ36984263-6EF9BB33-D3E9-468B-8A83-02582F47AF35Q37090161-8E878CBB-6368-4123-AC79-92155314C709Q37157298-F63FBB26-5BDD-404D-9263-879472A68A52Q37213114-02064952-EE79-4051-A8F5-FB0705660647Q37310301-C5481F8F-E525-48C4-803A-72687F1422B1Q37365333-FC2396FE-AF5F-4632-9DDE-4183DCE9CB18Q37373721-FA3F2748-56B8-42C9-AEDB-18D4AE2526A4Q37535064-A2FCB90D-91C2-4E96-B8F1-7A0F934B21DFQ37559828-801E7067-0012-473B-998E-2C1677B536ADQ37636276-A9AAC5E1-659D-4503-888D-10C10607E39F
P2860
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
description
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans Nature Communications
@fr
artikull shkencor
@sq
artículu científicu espublizáu en 2012
@ast
scientific journal article
@en
wetenschappelijk artikel
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в січні 2012
@uk
مقالة علمية (نشرت عام 2012)
@ar
name
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@ast
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@en
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@nl
type
label
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@ast
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@en
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@nl
prefLabel
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@ast
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@en
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@nl
P2093
P2860
P50
P3181
P356
P1476
Uncoupling of the endocannabin ...... se model of fragile X syndrome
@en
P2093
Andreas Frick
Daniele Piomelli
Marja Sepers
Melanie Ginger
Nicholas V DiPatrizio
P2860
P2888
P3181
P356
10.1038/NCOMMS2045
P407
P50
P577
2012-01-01T00:00:00Z
P5875
P6179
1038824051